BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31373248)

  • 1. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
    Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
    Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
    Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
    World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
    Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
    Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
    Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.
    Guntupalli SR; Zighelboim I; Kizer NT; Zhang Q; Powell MA; Thaker PH; Goodfellow PJ; Mutch DG
    Gynecol Oncol; 2012 Jan; 124(1):31-5. PubMed ID: 22030404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
    Weinberg LE; Kunos CA; Zanotti KM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis.
    Hertel JD; Huettner PC; Pfeifer JD
    Int J Gynecol Pathol; 2014 Mar; 33(2):127-34. PubMed ID: 24487466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus.
    Sarı ME; Meydanlı MM; Yalçın I; Şahin H; Çoban G; Çelik H; Kuşçu E; Gungor T; Ayhan A
    Oncol Res Treat; 2018; 41(12):750-754. PubMed ID: 30419557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.
    Panggid K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1044-8. PubMed ID: 21058438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower uterine segment involvement in lymphovascular space invasion and lymph node metastasis in endometrioid endometrial cancer.
    Cokmez H; Yilmaz A
    Ginekol Pol; 2019; 90(6):314-319. PubMed ID: 31276182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
    Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
    Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
    Ayhan A; Şahin H; Sari ME; Yalçin I; Haberal A; Meydanli MM
    Int J Gynecol Cancer; 2019 Mar; 29(3):505-512. PubMed ID: 30665899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
    de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
    PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.